122 related articles for article (PubMed ID: 37105506)
1. The myo-inositol biosynthesis rate-limiting enzyme ISYNA1 suppresses the stemness of ovarian cancer via Notch1 pathway.
Yang L; Yang M; Cui C; Long X; Li Y; Dai W; Lang T; Zhou Q
Cell Signal; 2023 Jul; 107():110688. PubMed ID: 37105506
[TBL] [Abstract][Full Text] [Related]
2. SNORD89 promotes stemness phenotype of ovarian cancer cells by regulating Notch1-c-Myc pathway.
Zhu W; Niu J; He M; Zhang L; Lv X; Liu F; Jiang L; Zhang J; Yu Z; Zhao L; Bi J; Yan Y; Wei Q; Huo H; Fan Y; Chen Y; Ding J; Wei M
J Transl Med; 2019 Aug; 17(1):259. PubMed ID: 31395064
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of CD133-Sustained Chemoresistant Cancer Stem-Like Cells in Human Ovarian Carcinoma.
Liu CL; Chen YJ; Fan MH; Liao YJ; Mao TL
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899775
[TBL] [Abstract][Full Text] [Related]
4. Exosomal release of microRNA-454 by breast cancer cells sustains biological properties of cancer stem cells via the PRRT2/Wnt axis in ovarian cancer.
Wang L; He M; Fu L; Jin Y
Life Sci; 2020 Sep; 257():118024. PubMed ID: 32598931
[TBL] [Abstract][Full Text] [Related]
5. Notch1 signaling contributes to stemness in head and neck squamous cell carcinoma.
Lee SH; Do SI; Lee HJ; Kang HJ; Koo BS; Lim YC
Lab Invest; 2016 May; 96(5):508-16. PubMed ID: 26927514
[TBL] [Abstract][Full Text] [Related]
6. Loss of Krüppel-like factor 9 facilitates stemness in ovarian cancer ascites-derived multicellular spheroids via Notch1/slug signaling.
Wang K; Liu S; Dou Z; Zhang S; Yang X
Cancer Sci; 2021 Oct; 112(10):4220-4233. PubMed ID: 34363722
[TBL] [Abstract][Full Text] [Related]
7. Regulation of myo-inositol biosynthesis by p53-ISYNA1 pathway.
Koguchi T; Tanikawa C; Mori J; Kojima Y; Matsuda K
Int J Oncol; 2016 Jun; 48(6):2415-24. PubMed ID: 27035231
[TBL] [Abstract][Full Text] [Related]
8. Galectin-3 supports stemness in ovarian cancer stem cells by activation of the Notch1 intracellular domain.
Kang HG; Kim DH; Kim SJ; Cho Y; Jung J; Jang W; Chun KH
Oncotarget; 2016 Oct; 7(42):68229-68241. PubMed ID: 27626163
[TBL] [Abstract][Full Text] [Related]
9. L1CAM promotes ovarian cancer stemness and tumor initiation via FGFR1/SRC/STAT3 signaling.
Giordano M; Decio A; Battistini C; Baronio M; Bianchi F; Villa A; Bertalot G; Freddi S; Lupia M; Jodice MG; Ubezio P; Colombo N; Giavazzi R; Cavallaro U
J Exp Clin Cancer Res; 2021 Oct; 40(1):319. PubMed ID: 34645505
[TBL] [Abstract][Full Text] [Related]
10. hPaf1/PD2 interacts with OCT3/4 to promote self-renewal of ovarian cancer stem cells.
Karmakar S; Seshacharyulu P; Lakshmanan I; Vaz AP; Chugh S; Sheinin YM; Mahapatra S; Batra SK; Ponnusamy MP
Oncotarget; 2017 Feb; 8(9):14806-14820. PubMed ID: 28122356
[TBL] [Abstract][Full Text] [Related]
11. Differential methylation of the gene encoding myo-inositol 3-phosphate synthase (Isyna1) in rat tissues.
Seelan RS; Pisano MM; Greene RM; Casanova MF; Parthasarathy RN
Epigenomics; 2011 Feb; 3(1):111-24. PubMed ID: 21841945
[TBL] [Abstract][Full Text] [Related]
12. Notch signaling plays a crucial role in cancer stem-like cells maintaining stemness and mediating chemotaxis in renal cell carcinoma.
Xiao W; Gao Z; Duan Y; Yuan W; Ke Y
J Exp Clin Cancer Res; 2017 Mar; 36(1):41. PubMed ID: 28279221
[TBL] [Abstract][Full Text] [Related]
13. Hypoxia potentiates gemcitabine-induced stemness in pancreatic cancer cells through AKT/Notch1 signaling.
Zhang Z; Han H; Rong Y; Zhu K; Zhu Z; Tang Z; Xiong C; Tao J
J Exp Clin Cancer Res; 2018 Nov; 37(1):291. PubMed ID: 30486896
[TBL] [Abstract][Full Text] [Related]
14. Loss of Mel-18 enhances breast cancer stem cell activity and tumorigenicity through activating Notch signaling mediated by the Wnt/TCF pathway.
Won HY; Lee JY; Shin DH; Park JH; Nam JS; Kim HC; Kong G
FASEB J; 2012 Dec; 26(12):5002-13. PubMed ID: 22954590
[TBL] [Abstract][Full Text] [Related]
15. Chemokine CCL20 promotes the paclitaxel resistance of CD44
Chen M; Su J; Feng C; Liu Y; Zhao L; Tian Y
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278466
[TBL] [Abstract][Full Text] [Related]
16. Musashi2 contributes to the maintenance of CD44v6+ liver cancer stem cells via notch1 signaling pathway.
Wang X; Wang R; Bai S; Xiong S; Li Y; Liu M; Zhao Z; Wang Y; Zhao Y; Chen W; Billiar TR; Cheng B
J Exp Clin Cancer Res; 2019 Dec; 38(1):505. PubMed ID: 31888685
[TBL] [Abstract][Full Text] [Related]
17. STON2 negatively modulates stem-like properties in ovarian cancer cells via DNMT1/MUC1 pathway.
Xu S; Yue Y; Zhang S; Zhou C; Cheng X; Xie X; Wang X; Lu W
J Exp Clin Cancer Res; 2018 Dec; 37(1):305. PubMed ID: 30518424
[TBL] [Abstract][Full Text] [Related]
18. Essential role of PLD2 in hypoxia-induced stemness and therapy resistance in ovarian tumors.
Muñoz-Galván S; Verdugo-Sivianes EM; Santos-Pereira JM; Estevez-García P; Carnero A
J Exp Clin Cancer Res; 2024 Feb; 43(1):57. PubMed ID: 38403587
[TBL] [Abstract][Full Text] [Related]
19. Musashi2 promotes the progression of pancreatic cancer through a novel ISYNA1-p21/ZEB-1 pathway.
Zhou L; Sheng W; Jia C; Shi X; Cao R; Wang G; Lin Y; Zhu F; Dong Q; Dong M
J Cell Mol Med; 2020 Sep; 24(18):10560-10572. PubMed ID: 32779876
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-NOTCH1-SOX2 signaling is important for maintaining cancer stem cells in ovarian cancer.
Seo EJ; Kim DK; Jang IH; Choi EJ; Shin SH; Lee SI; Kwon SM; Kim KH; Suh DS; Kim JH
Oncotarget; 2016 Aug; 7(34):55624-55638. PubMed ID: 27489349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
